Understanding Pacemaker-Induced Cardiomyopathy Incidence and Predictors in Patients with Right Ventricular Pacing: A Systematic Review

Abstract

This study aimed to figure out the incidence and predictors of pacemaker-induced cardiomyopathy (PICM) in patients with right ventricular (RV) pacing. We systematically searched in PubMed on March 18, 2020, for English language abstract and full-article journals, using the following criteria: pacemaker induced cardiomyopathy AND right ventricular AND pacemaker AND patients AND human NOT implantable cardioverter defibrillator NOT ICD NOT animal. Four studies were included in this review after filtering 35 studies through year of publication and abstract selection. The average PICM incidence from 1,365 patients included from the four studies was 10.7 to 13.7%. One study stated that preimplantation left ventricular ejection fraction (LVEF) was the predictor for the development of PICM. Three studies mentioned that RV pacing burden was the predictor for the development of PICM. However, the percentage differ in three studies: ≥20, >40, and 60%. In addition, one of the studies also included interventricular dyssynchrony as another predictor. The incidence of PICM in patients with RV pacing ranged from 10.7 to 13.7%. Preimplantation LVEF, interventricular dyssynchrony, and burden of RV pacing are reported as the predictors for the development of PICM in patients with RV pacing.

Keywords

heart pacing - cardiomyopathy - pacemaker

Publication History

Article published online:
01 October 2021

• References

• 1 Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004; 25 (01) 88-95
• 2 Wood MA, Ellenbogen KA. Cardiology patient pages. Cardiac pacemakers from the patient's perspective. Circulation 2002; 105 (18) 2136-2138
• 3 Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011; 34 (08) 1013-1027
• 4 Mulpuru SK, Madhavan M, McLeod CJ, Cha YM, Friedman PA. Cardiac pacemakers: function, troubleshooting, and management: part 1 of a 2-part series. J Am Coll Cardiol 2017; 69 (02) 189-210
• 5 Epstein AE, DiMarco JP, Ellenbogen KA. et al; American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013; 127 (03) e283-e352
• 6 Kotsakou M, Kioumis I, Lazaridis G. et al. Pacemaker insertion. Ann Transl Med 2015; 3 (03) 42
• 7 Lamas GA, Ellenbogen KA. Evidence base for pacemaker mode selection: from physiology to randomized trials. Circulation 2004; 109 (04) 443-451
• 8 Koo A, Stein A, Walsh R. Pacing-induced cardiomyopathy. Clin Pract Cases Emerg Med 2017; 1 (04) 362-364
• 9 Dreger H, Maethner K, Bondke H, Baumann G, Melzer C. Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years. Europace 2012; 14 (02) 238-242
• 10 Kaye G, Ng JY, Ahmed S, Valencia D, Harrop D, Ng ACT. The prevalence of pacing-induced cardiomyopathy (PICM) in patients with long term right ventricular pacing - is it a matter of definition?. Heart Lung Circ 2019; 28 (07) 1027-1033
• 11 Bansal R, Parakh N, Gupta A. et al. Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J Interv Card Electrophysiol 2019; 56 (01) 63-70
• 12 Kiehl EL, Makki T, Kumar R. et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 2016; 13 (12) 2272-2278
• 13 Kim JH, Kang KW, Chin JY, Kim TS, Park JH, Choi YJ. Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicentre, retrospective analysis over a 15-year period in South Korea. BMJ Open 2018; 8 (02) e019048
• 14 Abdin A, Yalin K, Zink MD. et al. Incidence and predictors of pacemaker induced cardiomyopathy: a single-center experience. J Electrocardiol 2019; 57: 31-34
• 15 Khurshid S, Epstein AE, Verdino RJ. et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 2014; 11 (09) 1619-1625
• 16 Safak E, Ince H, Gkouvatsou L. et al. Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: a midterm follow-up study. Eur J Med Res 2019; 24 (01) 23
• 17 Brignole M, Auricchio A, Baron-Esquivias G. et al; ESC Committee for Practice Guidelines (CPG), Document Reviewers. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34 (29) 2281-2329